Antiemetic Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Antiemetic Trends and Forecast
The future of the global antiemetic market looks promising with opportunities in the chemotherapy, post operative surgery, and pregnancy & gastroenteritis markets. The global antiemetic market is expected to reach an estimated $11.5 billion by 2030 with a CAGR of 6.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of nausea and vomiting, growing number of gastroenteritis patients, and rising government funding for research.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Antiemetic by Segment
The study includes a forecast for the global antiemetic by drug type, distribution channel, application, and region.
Antiemetic Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antiemetic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antiemetic companies profiled in this report include-
Lucintel forecasts that serotonin receptor antagonist will remain the largest segment over the forecast period due to the increase in demand for gravisetron and ondansetron, which are used to reduce nausea and vomiting following surgical operations..
Within this market, chemotherapy will remain the largest segment due to the increase in cancer diagnoses and the corresponding increase in the use of chemotherapy as a form of treatment.
APAC will remain the largest region over the forecast period due to surge in cancer population and growing incidences of gastroenteritis, and other diseases in the region.
Features of the Global Antiemetic Market
Market Size Estimates: Antiemetic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Antiemetic market size by drug type, distribution channel, application, and region in terms of value ($B).
Regional Analysis: Antiemetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug types, distribution channels, applications, and regions for the antiemetic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antiemetic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the antiemetic market size?
Answer: The global antiemetic market is expected to reach an estimated $11.5 billion by 2030.
Q2. What is the growth forecast for antiemetic market?
Answer: The global antiemetic market is expected to grow with a CAGR of 6.0% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the antiemetic market?
Answer: The major drivers for this market are increasing prevalence of nausea and vomiting, growing number of gastroenteritis patients, and rising government funding for research.
Q4. What are the major segments for antiemetic market?
Answer: The future of the antiemetic market looks promising with opportunities in the chemotherapy, post operative surgery, and pregnancy & gastroenteritis markets.
Q5. Who are the key antiemetic market companies?
Answer: Some of the key antiemetic companies are as follows:
Answer: Lucintel forecasts that serotonin receptor antagonist will remain the largest segment over the forecast period due to the increase in demand for gravisetron and ondansetron, which are used to reduce nausea and vomiting following surgical operations..
Q7. In antiemetic market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the largest region over the forecast period due to surge in cancer population and growing incidences of gastroenteritis, and other diseases in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the antiemetic market by drug type (antihistamines, serotonin receptor antagonists, dopamine receptor antagonists, neurokinin receptor antagonists, anticholinergics, and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies), application (chemotherapy, post operative surgery, pregnancy & gastroenteritis, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Antiemetic Market, Antiemetic Market Size, Antiemetic Market Growth, Antiemetic Market Analysis, Antiemetic Market Report, Antiemetic Market Share, Antiemetic Market Trends, Antiemetic Market Forecast, Antiemetic Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Antiemetic Trends and Forecast
The future of the global antiemetic market looks promising with opportunities in the chemotherapy, post operative surgery, and pregnancy & gastroenteritis markets. The global antiemetic market is expected to reach an estimated $11.5 billion by 2030 with a CAGR of 6.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of nausea and vomiting, growing number of gastroenteritis patients, and rising government funding for research.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Antiemetic by Segment
The study includes a forecast for the global antiemetic by drug type, distribution channel, application, and region.
Antiemetic Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:
- Antihistamines
- Serotonin Receptor Antagonists
- Dopamine Receptor Antagonists
- Neurokinin Receptor Antagonists
- Anticholinergics
- Others
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Chemotherapy
- Post Operative Surgery
- Pregnancy & Gastroenteritis
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antiemetic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antiemetic companies profiled in this report include-
- Abbott Laboratories,
- Benuvia Therapeutics
- Cipla
- Dr. Reddy’s Laboratories
- Eisai
- F. Hoffmann-La Roche
- Merck
- Novartis
- Pfizer
- Teva Pharmaceuticals
Lucintel forecasts that serotonin receptor antagonist will remain the largest segment over the forecast period due to the increase in demand for gravisetron and ondansetron, which are used to reduce nausea and vomiting following surgical operations..
Within this market, chemotherapy will remain the largest segment due to the increase in cancer diagnoses and the corresponding increase in the use of chemotherapy as a form of treatment.
APAC will remain the largest region over the forecast period due to surge in cancer population and growing incidences of gastroenteritis, and other diseases in the region.
Features of the Global Antiemetic Market
Market Size Estimates: Antiemetic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Antiemetic market size by drug type, distribution channel, application, and region in terms of value ($B).
Regional Analysis: Antiemetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug types, distribution channels, applications, and regions for the antiemetic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antiemetic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the antiemetic market size?
Answer: The global antiemetic market is expected to reach an estimated $11.5 billion by 2030.
Q2. What is the growth forecast for antiemetic market?
Answer: The global antiemetic market is expected to grow with a CAGR of 6.0% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the antiemetic market?
Answer: The major drivers for this market are increasing prevalence of nausea and vomiting, growing number of gastroenteritis patients, and rising government funding for research.
Q4. What are the major segments for antiemetic market?
Answer: The future of the antiemetic market looks promising with opportunities in the chemotherapy, post operative surgery, and pregnancy & gastroenteritis markets.
Q5. Who are the key antiemetic market companies?
Answer: Some of the key antiemetic companies are as follows:
- Abbott Laboratories,
- Benuvia Therapeutics
- Cipla
- Dr. Reddy’s Laboratories
- Eisai
- F. Hoffmann-La Roche
- Merck
- Novartis
- Pfizer
- Teva Pharmaceuticals
Answer: Lucintel forecasts that serotonin receptor antagonist will remain the largest segment over the forecast period due to the increase in demand for gravisetron and ondansetron, which are used to reduce nausea and vomiting following surgical operations..
Q7. In antiemetic market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the largest region over the forecast period due to surge in cancer population and growing incidences of gastroenteritis, and other diseases in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the antiemetic market by drug type (antihistamines, serotonin receptor antagonists, dopamine receptor antagonists, neurokinin receptor antagonists, anticholinergics, and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies), application (chemotherapy, post operative surgery, pregnancy & gastroenteritis, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Antiemetic Market, Antiemetic Market Size, Antiemetic Market Growth, Antiemetic Market Analysis, Antiemetic Market Report, Antiemetic Market Share, Antiemetic Market Trends, Antiemetic Market Forecast, Antiemetic Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL ANTIEMETIC MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Antiemetic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Antiemetic Market by Drug Type
3.3.1: Antihistamines
3.3.2: Serotonin Receptor Antagonists
3.3.3: Dopamine Receptor Antagonists
3.3.4: Neurokinin Receptor Antagonists
3.3.5: Anticholinergics
3.3.6: Others
3.4: Global Antiemetic Market by Distribution Channel
3.4.1: Retail Pharmacies
3.4.2: Hospital Pharmacies
3.4.3: Online Pharmacies
3.5: Global Antiemetic Market by Application
3.5.1: Chemotherapy
3.5.2: Post Operative Surgery
3.5.3: Pregnancy & Gastroenteritis
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Antiemetic Market by Region
4.2: North American Antiemetic Market
4.2.1: North American Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.2.2: North American Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
4.3: European Antiemetic Market
4.3.1: European Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.3.2: European Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
4.4: APAC Antiemetic Market
4.4.1: APAC Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.4.2: APAC Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
4.5: ROW Antiemetic Market
4.5.1: ROW Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.5.2: ROW Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Antiemetic Market by Drug Type
6.1.2: Growth Opportunities for the Global Antiemetic Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Antiemetic Market by Application
6.1.4: Growth Opportunities for the Global Antiemetic Market by Region
6.2: Emerging Trends in the Global Antiemetic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Antiemetic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antiemetic Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Abbott Laboratories,
7.2: Benuvia Therapeutics
7.3: Cipla
7.4: Dr. Reddy’s Laboratories
7.5: Eisai
7.6: F. Hoffmann-La Roche
7.7: Merck
7.8: Novartis
7.9: Pfizer
7.10: Teva Pharmaceuticals
2. GLOBAL ANTIEMETIC MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Antiemetic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Antiemetic Market by Drug Type
3.3.1: Antihistamines
3.3.2: Serotonin Receptor Antagonists
3.3.3: Dopamine Receptor Antagonists
3.3.4: Neurokinin Receptor Antagonists
3.3.5: Anticholinergics
3.3.6: Others
3.4: Global Antiemetic Market by Distribution Channel
3.4.1: Retail Pharmacies
3.4.2: Hospital Pharmacies
3.4.3: Online Pharmacies
3.5: Global Antiemetic Market by Application
3.5.1: Chemotherapy
3.5.2: Post Operative Surgery
3.5.3: Pregnancy & Gastroenteritis
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Antiemetic Market by Region
4.2: North American Antiemetic Market
4.2.1: North American Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.2.2: North American Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
4.3: European Antiemetic Market
4.3.1: European Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.3.2: European Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
4.4: APAC Antiemetic Market
4.4.1: APAC Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.4.2: APAC Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
4.5: ROW Antiemetic Market
4.5.1: ROW Antiemetic Market by Drug Type: Antihistamines, Serotonin Receptor Antagonists, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Anticholinergics, and Others
4.5.2: ROW Antiemetic Market by Application: Chemotherapy, Post Operative Surgery, Pregnancy & Gastroenteritis, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Antiemetic Market by Drug Type
6.1.2: Growth Opportunities for the Global Antiemetic Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Antiemetic Market by Application
6.1.4: Growth Opportunities for the Global Antiemetic Market by Region
6.2: Emerging Trends in the Global Antiemetic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Antiemetic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antiemetic Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Abbott Laboratories,
7.2: Benuvia Therapeutics
7.3: Cipla
7.4: Dr. Reddy’s Laboratories
7.5: Eisai
7.6: F. Hoffmann-La Roche
7.7: Merck
7.8: Novartis
7.9: Pfizer
7.10: Teva Pharmaceuticals
